13F-HR filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 43 holding rows worth $698,705,931.
- Accession
- 0001172661-23-002203
- Filer
- CIK 1792126
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 43 entries on the cover page, a total value of $698,705,931 stated on the cover page (in dollars after the unit check, H1), rows summing to $698,705,931 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 800,000 | $52,768,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 3,600,000 | $49,428,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,250,000 | $43,987,500 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,500,000 | $38,775,000 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 1,520,000 | $36,981,600 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 900,000 | $32,211,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 220,000 | $30,322,600 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 100,000 | $27,803,000 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 500,000 | $24,720,000 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 5,536,666 | $24,638,164 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 950,000 | $24,168,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 200,000 | $20,244,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,700,000 | $19,584,000 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 100,000 | $18,164,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,797,501 | $16,141,581 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 150,000 | $16,083,000 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 750,000 | $15,952,500 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 900,000 | $15,417,000 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 400,000 | $15,304,000 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 150,000 | $14,586,000 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,044,960 | $13,897,968 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 350,000 | $13,524,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,743,875 | $12,991,246 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 50,000 | $12,113,000 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 410,000 | $11,746,500 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 525,000 | $11,124,750 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,000,000 | $10,790,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 700,000 | $9,562,000 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 270,000 | $9,045,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 401,229 | $8,786,915 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 350,000 | $8,326,500 | dollars as filed | |
| GERON CORP | 374163103 | COM | 3,550,000 | $7,703,500 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 1,500,000 | $6,780,000 | dollars as filed | |
| MORPHOSYS AG | 617760202 | ADR | 1,500,000 | $5,940,000 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 300,000 | $5,598,000 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 300,000 | $4,698,000 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 400,000 | $3,488,000 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 188,390 | $1,844,338 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 87,673 | $1,408,905 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 1,000,000 | $874,000 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 421,184 | $627,564 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 280,000 | $548,800 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 66,666 | $8,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-23-002203 | this filing | 2023-05-15 | acceptance time not in the bulk data set |